Wang R - Search Results

1

Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non-small cell lung cancer harboring BRAF V600E mutation: A case report.

Huang Z, Wang Y, Li B, Xu Y, Huang G, Song Y, Li J, Song L, Wang J, Wang R, Liang N, Li S. Huang Z, et al. Among authors: wang j, wang y, wang r. Thorac Cancer. 2024 Aug;15(24):1825-1828. doi: 10.1111/1759-7714.15409. Epub 2024 Jul 17. Thorac Cancer. 2024. PMID: 39020500 Free PMC article.

2

Dual targeting PET tracer [⁶⁸Ga]Ga-FAPI-RGD in patients with lung neoplasms: a pilot exploratory study.

Wang R, Jakobsson V, Wang J, Zhao T, Peng X, Li B, Xue J, Liang N, Zhu Z, Chen X, Zhang J. Wang R, et al. Among authors: wang j. Theranostics. 2023 May 15;13(9):2979-2992. doi: 10.7150/thno.86007. eCollection 2023. Theranostics. 2023. PMID: 37284441 Free PMC article.

3

A Single-Arm, Low-Dose, Prospective Study of ¹⁷⁷Lu-EB-PSMA Radioligand Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.

Wang G, Zang J, Jiang Y, Liu Q, Sui H, Wang R, Fan X, Zhang J, Zhu Z, Chen X. Wang G, et al. Among authors: wang r. J Nucl Med. 2023 Apr;64(4):611-617. doi: 10.2967/jnumed.122.264857. Epub 2022 Nov 3. J Nucl Med. 2023. PMID: 36328486 Free article.

4

Comparison of novel PSMA-targeting [¹⁷⁷Lu]Lu-P17-087 with its albumin binding derivative [¹⁷⁷Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study.

Li L, Wang J, Wang G, Wang R, Jin W, Zang J, Sui H, Jia C, Jiang Y, Hong H, Zhu L, Alexoff D, Ploessl K, Kung HF, Zhu Z. Li L, et al. Among authors: wang g, wang j, wang r. Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2794-2805. doi: 10.1007/s00259-024-06721-x. Epub 2024 Apr 25. Eur J Nucl Med Mol Imaging. 2024. PMID: 38658392

5

Synthesis, preclinical evaluation and pilot clinical translation of [⁶⁸Ga]Ga-PMD22, a novel nanobody PET probe targeting CLDN18.2 of gastrointestinal cancer.

Wang R, Bai Z, Zhong W, Li C, Wang J, Xiang J, Du J, Jia B, Zhu Z. Wang R, et al. Among authors: wang j. Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3731-3743. doi: 10.1007/s00259-024-06808-5. Epub 2024 Jun 27. Eur J Nucl Med Mol Imaging. 2024. PMID: 38926162

6

Peptide Receptor Radionuclide Therapy of Late-Stage Neuroendocrine Tumor Patients with Multiple Cycles of ¹⁷⁷Lu-DOTA-EB-TATE.

Liu Q, Zang J, Sui H, Ren J, Guo H, Wang H, Wang R, Jacobson O, Zhang J, Cheng Y, Zhu Z, Chen X. Liu Q, et al. Among authors: wang h, wang r. J Nucl Med. 2021 Mar;62(3):386-392. doi: 10.2967/jnumed.120.248658. Epub 2020 Aug 21. J Nucl Med. 2021. PMID: 32826319 Free PMC article.

7

Molecular imaging of HER2 expression in breast cancer patients using a novel peptide-based tracer ^99mTc-HP-Ark2: a pilot study.

Shi J, Du S, Wang R, Gao H, Luo Q, Hou G, Zhou Y, Zhu Z, Wang F. Shi J, et al. Among authors: wang f, wang r. J Transl Med. 2023 Jan 11;21(1):19. doi: 10.1186/s12967-022-03865-y. J Transl Med. 2023. PMID: 36631812 Free PMC article.

8

The value of ¹⁸F-FDG PET/CT in the systemic evaluation of patients with Rosai-Dorfman disease: a retrospective study and literature review.

Lu X, Wang R, Zhu Z. Lu X, et al. Among authors: wang r. Orphanet J Rare Dis. 2023 May 13;18(1):116. doi: 10.1186/s13023-023-02711-8. Orphanet J Rare Dis. 2023. PMID: 37179326 Free PMC article. Review.

9

A prospective head-to-head comparison of [⁶⁸Ga]Ga-P16-093 and [⁶⁸Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer.

Wang G, Li L, Zhu M, Zang J, Wang J, Wang R, Yan W, Zhu L, Kung HF, Zhu Z. Wang G, et al. Among authors: wang j, wang r. Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):3126-3136. doi: 10.1007/s00259-023-06283-4. Epub 2023 May 26. Eur J Nucl Med Mol Imaging. 2023. PMID: 37233785 Free PMC article. Clinical Trial.

10

Glucagon-Like Peptide-1 Receptor-Targeted PET/CT With 68 Ga-HBED-CC-Exendin-4 in Localizing Insulinoma : A Head-to-Head Comparison to 68 Ga-NOTA-Exendin-4.

Li L, Wang G, Wang J, Ma H, Chen J, Wang R, Pan Q, Hong H, Jin W, Kung HF, Zhu L, Luo Y, Zhu Z. Li L, et al. Among authors: wang g, wang j, wang r. Clin Nucl Med. 2025 Jan 1;50(1):38-43. doi: 10.1097/RLU.0000000000005533. Epub 2024 Nov 8. Clin Nucl Med. 2025. PMID: 39499011

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42,607 results

Search Page

Filters